Cleared Traditional

K201756 - Reprocessed MyoSure Tissue Removal Device, Reprocessed MyoSure REACH Tissue Removal Device, Reprocessed MyoSure LITE Tissue Removal Device, Reprocessed MyoSure XL Tissue Removal Device, Reprocessed MyoSure XL Tissue Removal Device for Fluent

K201756 is an FDA 510(k) clearance for Reprocessed MyoSure Tissue Removal Device, manufactured by Stryker Sustainability Solutions. The device is a Class 2 Obstetrics & Gynecology device with product code HIH cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K201756 · Stryker Sustainability Solutions · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
88d
Days
Class 2
Risk

K201756 is an FDA 510(k) clearance for the Reprocessed MyoSure Tissue Removal Device, Reprocessed MyoSure REACH Tissue R.... Classified as Hysteroscope (and Accessories) (product code HIH), Class II - Special Controls.

Submitted by Stryker Sustainability Solutions (Tempe, US). The FDA issued a Cleared decision on September 25, 2020 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.1690 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Stryker Sustainability Solutions devices

FDA 510(k) Submission Details - K201756

510(k) Number K201756 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2020
Decision Date September 25, 2020
Days to Decision 88 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 160d · This submission: 88d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HIH Device Classification - Class 2, Special Controls

Product Code HIH Hysteroscope (and Accessories)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - HIH Hysteroscope (and Accessories)

All 143
Devices cleared under the same product code (HIH) and FDA review panel - the closest regulatory comparables to K201756.
HTx Disposable Hysteroscope System
K211227 · Acuvu, Inc. · Sep 2021
BenestaTM Tissue Removal Device
K192811 · Caldera Medical, Inc. · Oct 2020
Schoelly Cystoscopes/Hysteroscopes and Accessories
K201970 · Schoelly Fiberoptic GmbH · Oct 2020
Benesta Hysteroscope
K192822 · Caldera Medical, Inc. · Sep 2020
Endosee System
K200038 · CooperSurgical, Inc. · Feb 2020
LiNA OperaScope with HDMI cable and on-board LCD - 6 units, LiNA OperaScope Recording Module
K193007 · Lina Medical Aps · Jan 2020